Introduction: Eczema, also known as atopic dermatitis, is a common skin condition characterized by dry, itchy skin. While ...

Eczema is a chronic skin condition that shares similarities with autoimmune skin conditions, but it’s not an autoimmune ...

Ebglyss (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for adults and children 12 years of age and older who weigh at least ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

“The only thing that helps my eczema now is big strong medications and love from friends and family. I still moisturise, take ...

By Hector MacKenzie via SWNS A mom is raising awareness by sharing pictures of her eleven-year-old daughter's eczema - which ...

INDIANAPOLIS–The U.S. Food and Drug Administration has approved Eli Lilly’s new treatment for moderate to severe eczema. It’s ...

Eli Lilly and Co. ($LLY) announced that the U.S. Food and Drug Administration (FDA) had approved its atopic dermatitis ...

A mom is raising awareness by sharing pictures of her eleven-year-old daughter's eczema - which has caused pain, itching, and ...

Both prurigo nodularis and eczema are chronic skin conditions that can cause intense itchiness. Doctors can usually diagnose both with a physical exam. Treatment typically focuses on reducing ...

Freya McGreevy, 27, has suffered from severe eczema all her life - with her painful skin condition even causing her to be ...

Sept. 17, 2024 – The FDA has approved a new treatment for persistent eczema called Ebglyss that eventually only needs to be taken once per month, offering a less frequent maintenance dose ...